By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery and development of targeted biotherapeutics to treat serious diseases and conditions601K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States601K100.00%